Patent Assignment
Reel/Frame 021962/0922
Assignment of Assignor's Interest
Recorded: 2008-12-11
Pages: 2
Assignor
URIGEN PHARMACEUTICALS, INC.
Executed: 2008-10-22
Assignee
JUVARIS BIOTHERAPEUTICS, INC.
863A MITTEN ROAD, BURLINGAME, CALIFORNIA, 94010
Covered Property
(1)
Cationic Lipid:Dna Complexes for Gene Targeting
Patent:
6,344,446 →
Application:
09/184,771 →
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Certificate of Ownership and Merger
Sep 23, 1999
From: MEGABIOS CORPORATION
To: VALENTIS, INC.
Reel/Frame 010247/0566 →
Merger
Dec 11, 2008
From: VALENTIS, INC.
To: URIGEN PHARMACEUTICALS, INC.
Reel/Frame 021962/0897 →
Security Agreement
Oct 4, 2011
From: JUVARIS BIOTHERAPEUTICS, INC.
To: TRIPLEPOINT CAPITAL LLC
Reel/Frame 027015/0765 →
Release of Security Interest
Oct 6, 2015
From: TRIPLEPOINT CAPITAL LLC
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 036739/0195 →